SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009753
Filing Date
2016-11-09
Accepted
2016-11-09 06:31:19
Documents
95
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20160930x10q.htm 10-Q 2649713
2 EX-10.1 amph-20160930ex101d7df43.htm EX-10.1 933207
3 EX-31.1 amph-20160930ex3117ded3f.htm EX-31.1 23602
4 EX-31.2 amph-20160930ex312a51440.htm EX-31.2 23756
5 EX-32.1 amph-20160930ex3215bd57e.htm EX-32.1 12112
6 EX-32.2 amph-20160930ex322320e41.htm EX-32.2 12144
  Complete submission text file 0001558370-16-009753.txt   12234796

Data Files

Seq Description Document Type Size
7 EX-101.INS amph-20160930.xml EX-101.INS 2865117
8 EX-101.SCH amph-20160930.xsd EX-101.SCH 74567
9 EX-101.CAL amph-20160930_cal.xml EX-101.CAL 61839
10 EX-101.DEF amph-20160930_def.xml EX-101.DEF 261061
11 EX-101.LAB amph-20160930_lab.xml EX-101.LAB 520730
12 EX-101.PRE amph-20160930_pre.xml EX-101.PRE 467847
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 161982735
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences